why choose us

First received: June 01, 2023

Clinical Trial: Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement

Study Status: Completed

Recruit Status: RECRUITING

Condition: Surgery-Complications

Study Type: OBSERVATIONAL


Official Title: Quality and Safety Outcomes: Prospective Follow Up Registry on FDA Cleared Acellular Fish Skin Grafts in Soft Tissue Reinforcement.

Brief Summary: Registry Objectives The overall objective of the registry is to collect quality and safety data to assess the long-term outcomes of Kerecis Omega3 SurgiBind in surgical procedures to reinforce soft tissue and prevent surgical complications.The ultimate goal of the registry is to enhance the quality of care, patient outcomes and establish a resource to facilitate the use of fish skin in preventing surgical wound dehiscence and surgical site infection.

Read more